Newsroom | 3247 results
Sorted by: Latest
-
AngelEye Health Secures Additional $9 Million to Accelerate Innovation in Neonatal and Pediatric Care
NASHVILLE, Tenn.--(BUSINESS WIRE)--AngelEye Health, a leader in neonatal and pediatric services, today announced the closing of a $9 million Series C funding round. In addition to the equity financing, AngelEye has secured a complementary debt facility from Live Oak Bank to strategically extend the company’s growth capital. The combined funding will enable AngelEye to accelerate product innovation, expand its commercial footprint, and further advance its mission to transform neonatal and pediat...
-
The MolinaCares Accord Commits $200,000 to Fund Maternal Health Navigators in Mississippi
JACKSON, Miss.--(BUSINESS WIRE)--The MolinaCares Accord commits $200,000 to fund maternal health navigators in Mississippi....
-
The Mother Baby Center Locations at United and Mercy Hospitals Earn Top Rating from U.S. News and World Report
MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--The Mother Baby Center locations at United and Mercy hospitals earn top U.S. News maternity care honors for excellence in labor and delivery....
-
Baby Bath Products (Shampoo, Conditioner, Soap & Shower Gel, Shower Oil, Bath Additives, Other) Market Intelligence 2020-2030 by Price, Distribution Channel and Region - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Baby Bath Products Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Baby Bath Products Market, valued at USD 5.88 Billion in 2024, is projected to experience a CAGR of 7.01% to reach USD 8.83 Billion by 2030. Market growth is primarily driven by increasing parental awareness regarding infant hygiene and health, coupled with rising disposable incomes in emerging econ...
-
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive interim results from its ongoing POLARIS clinical development program evaluating ETX101 in children with SCN1A+ Dravet syndrome. The data will be featured in an oral presentation at the American Epilepsy Society (AES) Annual Meeting today and again tomorrow in a poster session. The POLARIS program...
-
Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide
SYDNEY--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ is now available for families across Australia and New Zealand. Dream Sock recently received approval from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous medical device standards in the region. With this milestone achieved, families can now purchase Dream Sock through Owlet’s local website and select retail partners. “Bringi...
-
MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older
DURHAM, N.C.--(BUSINESS WIRE)--FDA approves expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss....
-
MaxHSA and Avidia Health Announce Strategic Partnership to Help Increase HSA Deposits
ATLANTA--(BUSINESS WIRE)--MaxHSA, a gamified Health Savings Account (HSA) engagement platform developed by Benegames, Inc., today announced a strategic partnership with Avidia Health, a leading HSA administrator, to make MaxHSA’s innovative savings solution available to Avidia accountholders nationwide. The collaboration marks a major step in helping more Americans maximize their financial contributions to HSAs by rewarding everyday spending. “We’re thrilled to partner with Avidia, one of the m...
-
Boston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More Accessible
BOSTON--(BUSINESS WIRE)--Boston IVF, one of the nation’s leading reproductive service providers and a pioneer in IVF research, today announced new partnerships with Gaia, the first provider of value-based family building, and PatientFi, a modern, patient-friendly financing platform offering zero-interest plan options*, flexible monthly terms up to 84 months**, and financing that covers the entire fertility journey from treatments, and medications to labs, testing, and out-of-pocket expenses. Th...
-
Owlet Earns Spot on Fast Company’s 2025 Brands That Matter List
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, is proud to announce its inclusion in Fast Company’s annual Brands That Matter list. This recognition celebrates brands that create deep emotional connection and cultural relevance, not just customer acquisition, through clear purpose, originality, and measurable business impact. “We’re honored to be recognized by Fast Company as a brand that truly matters,” said Jonathan Ha...